Satellos Bioscience, Inc. (MSLE)
6.25
+0.66
(+11.81%)
USD |
NASDAQ |
Apr 08, 16:00
6.305
+0.06
(+0.88%)
After-Hours: 20:00
Satellos Bioscience Total Liabilities (Quarterly) : 4.105M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 20.56M |
| Oncolytics Biotech, Inc. | 11.38M |
| Aurinia Pharmaceuticals, Inc. | 189.26M |
| Edesa Biotech, Inc. | 0.7562M |
| Lexaria Bioscience Corp. | 1.527M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.89M |
| Shareholders Equity (Quarterly) | 27.78M |
| Current Ratio | 7.767 |